US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
US Biobanking Market Industry Trends and Forecast to 2034: Segmented by (Sample, Service, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$973.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.42 Bn | — | — |
| 2025 (base) | $1.50 Bn | +$81.1 Mn | — |
| 2026 (forecast) | $1.59 Bn | +$85.7 Mn | +5.7% |
| 2027 (forecast) | $1.68 Bn | +$90.6 Mn | +11.7% |
| 2028 (forecast) | $1.78 Bn | +$95.8 Mn | +18.1% |
| 2029 (forecast) | $1.88 Bn | +$101.2 Mn | +24.8% |
| 2030 (forecast) | $1.98 Bn | +$107.0 Mn | +31.9% |
| 2031 (forecast) | $2.10 Bn | +$113.1 Mn | +39.5% |
| 2032 (forecast) | $2.22 Bn | +$119.6 Mn | +47.4% |
| 2033 (forecast) | $2.34 Bn | +$126.4 Mn | +55.8% |
| 2034 (forecast) | $2.48 Bn | +$133.6 Mn | +64.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.50 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.48 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Sample, service and end user (see all) |
| Key players | Thermo Fisher Scientific Inc., Azenta Life Sciences, Qiagen N.V., BioIVT, Hamilton Company (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Biobanking collects, stores and manages blood, tissue and DNA samples with health data for research.
Key segments of the biobanking market include sample (Blood, Tissue and DNA and RNA) and service (Storage, Processing and Data Management).
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the biobanking market.
Routine use of genomics in screening, pharmacy and primary care gives the biobanking market large room to grow.
Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the biobanking market.
The biobanking market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[1]
[1] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Licensing, quality standards and payment models from public and private payers shape how biobanking services are delivered and paid for in US. Government health programs and insurance coverage are key to access.
What doctors and scientists are doing in Biobanking right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US
US
US
Pharmaceuticals · US
Digital Health · US
Medical Devices · US
Digital Health · US
Medical Devices · US
Medical Devices · US